Moreover, the preponderance of evidence among studies investigating the effects of TZDs against breast cancer suggests that both in vivo and in vitro apoptosis induction and inhibition of angiogenesis, proliferation, and invasion are performed by PPAR-γ ligands. This evidence concerns the gene PPARG and breast carcinoma.